Revenue: The sum of all revenue fields included for a company's operating activities.
Bristol Myers Squibb Company (BMY) had Revenue of $11.20B for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
Revenue |
$11.20B |
$2.46B |
|
$3.03B |
|
$8.17B |
|
$8.23B |
|
$2.97B |
|
-- |
|
$2.97B |
|
$2.97B |
|
$2.46B |
|
$2.46B |
|
$2.46B |
|
$2.46B |
|
$2.97B |
|
$3.98B |
|
2.03B |
|
2.04B |
|
$1.21 |
|
$1.20 |
|
Balance Sheet Financials | |
$30.78B |
|
$7.21B |
|
$61.64B |
|
$92.43B |
|
$24.07B |
|
$46.16B |
|
$50.91B |
|
$74.98B |
|
$17.45B |
|
$-26.77B |
|
$17.45B |
|
2.04B |
|
Cash Flow Statement Financials | |
$1.95B |
|
$-499.00M |
|
$-993.00M |
|
$10.35B |
|
$10.88B |
|
$528.00M |
|
$144.00M |
|
$-1.26B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.28 |
|
-- |
|
-- |
|
0.73 |
|
2.85 |
|
72.92% |
|
26.52% |
|
26.52% |
|
-- |
|
26.52% |
|
21.93% |
|
$1.69B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.14 |
|
1.04 |
|
86.79 |
|
14.11% |
|
-9.20% |
|
2.66% |
|
3.87% |
|
$8.57 |
|
$0.83 |
|
$0.96 |